PRTN3 and Arthritis: Although our RA population is characterized by a relatively high rate of seronegative and ACPA-negative patients, perhaps reflecting a more difficult-to-diagnose arthritis population in our tertiary care setting, the ability of mtDNA measurements to distinguish between HC and RA was observed regardless of the serological status of the RA patients.